Andoy, Robella .
HRN: 17-28-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2026
MUPIROCIN 2%, 15G (TUBE)
02/15/2026
02/22/2026
TOPICAL
Apply To Post Op Site
OD
SP 1LTCS
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines